Gestational Trophoblastic Disease Study Notes

Gestational Trophoblastic Disease (GTD)

• Definition: Spectrum of placental-related tumors originating in the placenta.
    - Types:
      - Molar:
          - Benign (80% of cases)
          - Hydatidiform mole: Most common type of GTD.
      - Non-molar tumors:
          - Gestational trophoblastic neoplasia or malignant GTD.
          - Medical cause unknown; potential genetic basis being investigated.

Hydatidiform Mole

• Description:
    - A benign proliferating growth of the trophoblast.
    - Occurrence rate: Approximately 1 to 2 in 1,000 pregnancies.
    - Characterization: Edematous, cystic, vascular transparent vesicles that cluster like grapes without any viable fetus.
    - Result: Non-viable pregnancy.
    - Mechanism: Proliferation of placental and trophoblastic cells absorbs fluid from maternal blood, leading to vesicle formation.

Types of Hydatidiform Mole

• Categories:
    - Complete Hydatidiform Mole:
      - No fetal tissue present.
    - Partial Hydatidiform Mole:
      - Usually resembles missed or incomplete abortion appearance.

• Risks:
    - Approximately 10 to 15% of cases may develop into invasive moles, which can lead to choriocarcinoma (malignant transformation).

Spectrum of Gestational Trophoblastic Neoplasia

• Components:
    - Complete hydatidiform mole
    - Partial hydatidiform mole
    - Coexistent mole and live fetus
    - Invasive mole
    - Choriocarcinoma
    - Placental site trophoblastic tumor

Risk Factors

• Maternal age more susceptible:
    - Under 20 years old
    - Over 35 years old

• History:
    - Previous molar pregnancy increases risk.
    - Current molar pregnancy.

• Anatomical Factors:
    - Normal uterus vs. abnormal cyst development in the early placenta.

Assessment of GTD

• Symptoms:
    - Amenorrhea (absence of menstruation)
    - Severe nausea and vomiting
    - Abnormal uterine bleeding
    - Enlarged uterus (as assessed through fundal height)
    - Abdominal cramping and potential expulsion of vesicles resembling grape-like cysts
    - Pelvic pressure or pain

Diagnosis and Medical Treatment

• Diagnosis Methods:
    - Ultrasound (preferably transvaginal)
    - Measurement of hCG (human chorionic gonadotropin) levels via blood draw.

• Treatment Plans:
    - Chemotherapy for invasive moles (particularly effective drug: Methotrexate).
    - For benign conditions: Immediate evacuation using suction, dilation, and curettage of the mole.
    - Follow-up:
        - Regular monitoring of hCG levels for at least 6 months to detect potential neoplasia.
        - Pregnancy Guidelines:
          - Advise against pregnancy for at least one year post-treatment to mitigate risks.

Care Management

• Post-Evacuation Considerations:
    - Monitor for hemorrhage.
    - Assess uterine recovery and health.
    - Provide emotional support to the patient.
    - Explain the necessity of follow-up care related to serial hCG levels.

Nursing Assessment and Clinical Management

• Symptoms and signs are often similar to those seen in spontaneous abortion, especially by around 12 weeks of gestation.

• Diagnosis typically confirmed by ultrasound visualization.

• High levels of hCG are key indicators in GTD.

• Nursing Management Includes:
    - Preoperative preparation
    - Emotional support
    - Patient education regarding treatment options, serial hCG monitoring, and potential need for prophylactic chemotherapy.